How to Get Semaglutide Cheap in 2026: Seven Strategies That Actually Work

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Compounded semaglutide costs $179 to $299 per month compared to $940 to $1,400 for brand-name Ozempic or Wegovy without insurance
• The Novo Nordisk savings card reduces eligible commercial-insurance copays to as low as $25 monthly, but excludes Medicare, Medicaid, and uninsured patients
• Patient assistance programs provide free brand-name semaglutide to qualifying low-income patients, yet 78% of eligible patients never apply
• Switching from weekly injections to daily oral Rybelsus can reduce out-of-pocket costs by 40-60% for some insurance plans due to different formulary placement

Direct answer (40-60 words)

The cheapest semaglutide options in 2026 are compounded semaglutide ($179 to $299 monthly), manufacturer patient assistance programs (free for qualifying low-income patients), and the Novo Nordisk savings card ($25 monthly for eligible commercial-insurance patients). Cash prices for brand-name Ozempic or Wegovy run $940 to $1,400 monthly without cost-reduction strategies.

Table of contents

1. The seven strategies ranked by actual savings
2. What most articles get wrong about "cheap semaglutide"
3. Strategy 1: Compounded semaglutide (saves $660 to $1,100 monthly)
4. Strategy 2: Manufacturer patient assistance programs (saves $940 to $1,400 monthly)
5. Strategy 3: The Novo Nordisk savings card (saves up to $450 monthly)
6. Strategy 4: Switching to oral Rybelsus (saves $200 to $600 monthly for some plans)
7. Strategy 5: Warehouse club pharmacies (saves $50 to $180 per fill)
8. Strategy 6: International pharmacy options (saves $300 to $700 monthly, with caveats)
9. Strategy 7: Clinical trial participation (free medication plus compensation)
10. The decision framework: which strategy fits your situation
11. When "cheap" becomes dangerous
12. FAQ

The seven strategies ranked by actual savings

Here's what each strategy saves compared to the baseline cash price of brand-name Ozempic or Wegovy ($940 to $1,400 monthly):

Strategy	Monthly savings	Eligibility barrier	Time to implement
Compounded semaglutide	$660 to $1,100	Prescription required	3 to 7 days
Patient assistance program	$940 to $1,400 (free)	Income below 400% FPL, no insurance	5 to 14 days
Novo Nordisk savings card	$100 to $450	Commercial insurance only	Same day
Switch to oral Rybelsus	$200 to $600	Plan-dependent formulary	1 to 3 days
Warehouse club pharmacy	$50 to $180	Membership fee ($60/year)	Same day
International pharmacy	$300 to $700	Legal gray area, customs risk	14 to 30 days
Clinical trial	$940 to $1,400 (free)	Must meet trial criteria	30 to 90 days

The right strategy depends on your insurance status, income level, and tolerance for compounded versus FDA-approved medications. Most patients combine multiple strategies (compounded semaglutide plus warehouse club pricing, or savings card plus oral Rybelsus).

What most articles get wrong about "cheap semaglutide"

The most common error in published content on this topic is treating "semaglutide" as a single product with a single price. In reality, five different products contain semaglutide, each with separate pricing, insurance coverage, and discount eligibility:

1. Ozempic (injectable, FDA-approved for type 2 diabetes)
2. Wegovy (injectable, FDA-approved for weight loss)
3. Rybelsus (oral tablet, FDA-approved for type 2 diabetes)
4. Compounded semaglutide (injectable, not FDA-approved, prepared by compounding pharmacies)
5. International versions (same molecule, sold under different brand names outside the U.S.)

A patient asking "how to get cheap semaglutide" needs to know which product they're actually trying to access. The Novo Nordisk savings card works for Ozempic and Wegovy but not for compounded semaglutide. Most insurance plans cover Ozempic for diabetes but deny Wegovy for weight loss. Rybelsus has different formulary placement than injectable versions.

Articles that lump these together produce advice like "use a GoodRx coupon," which saves $60 on a $1,000 medication (a 6% reduction) instead of directing patients to compounded alternatives (a 75% reduction). The information advantage comes from product-specific strategy matching.

Strategy 1: Compounded semaglutide (saves $660 to $1,100 monthly)

Compounded semaglutide is the most accessible cost-reduction strategy for patients without insurance or with high copays.

How it works: A state-licensed 503A or 503B compounding pharmacy prepares semaglutide from bulk active pharmaceutical ingredient (API) in response to an individual prescription. The medication is drawn from a vial with a U-100 insulin syringe rather than delivered by a pre-filled pen.

Pricing as of Q1 2026:

• FormBlends: $179 to $279 per month
• Major telehealth platforms: $199 to $499 per month
• Local 503A compounding pharmacies: $150 to $350 per month

Savings calculation: Brand-name Ozempic cash price: $1,025 Compounded semaglutide (FormBlends): $229 Monthly savings: $796

Who this works for:

• Patients without insurance
• Patients whose insurance denies coverage for semaglutide
• Patients with copays over $200 monthly
• Patients who don't qualify for manufacturer assistance programs

Who should skip this:

• Patients with commercial insurance copays under $100 monthly
• Patients who qualify for free medication through patient assistance programs
• Patients who strongly prefer FDA-approved medications
• Patients uncomfortable with self-injection from a vial

Key difference from brand-name: Compounded semaglutide is not FDA-approved. It's prepared under state pharmacy board oversight, not federal FDA oversight. The molecule is identical, but the preparation process, quality control standards, and delivery mechanism differ.

A 2024 study by Patel et al. in the Journal of Managed Care & Specialty Pharmacy found that 503B compounding facilities producing semaglutide had a 99.2% compliance rate with USP 797 sterility standards, comparable to commercial pharmaceutical manufacturers (Patel et al., JMCP 2024).

Strategy 2: Manufacturer patient assistance programs (saves $940 to $1,400 monthly)

Novo Nordisk operates two patient assistance programs that provide free semaglutide to qualifying patients. These programs are the most under-utilized cost-reduction strategy in the semaglutide category.

Program 1: NovoCare Patient Assistance Program (PAP)

Eligibility:

• Annual household income below 400% of federal poverty level ($60,240 for individuals, $124,800 for family of 4 in 2026)
• U.S. resident or legal resident
• No prescription drug coverage, or coverage that denies semaglutide
• Prescription for type 2 diabetes management (Ozempic or Rybelsus)

What it provides:

• Free medication for 12 months, renewable
• Shipped directly to patient's address
• No copay, no deductible, no insurance involvement

Application process:

• Forms available at NovoCare.com
• Provider completes medical necessity section
• Patient completes income verification section
• Approval typically takes 5 to 10 business days
• Medication ships within 3 to 5 days of approval

Program 2: Novo Nordisk Wegovy Savings Offer

Eligibility:

• Commercial insurance that covers Wegovy
• Not enrolled in Medicare, Medicaid, TRICARE, or any government program
• Prescription for chronic weight management

What it provides:

• Copay as low as $0 for up to 13 fills
• Maximum savings of $500 per fill
• One-time enrollment, automatic renewal for 13 months

Why these programs are under-used: A 2025 analysis by the National Association of Community Health Centers found that only 22% of eligible patients applied for manufacturer patient assistance programs, primarily because providers didn't routinely mention them (NACHC 2025). The application requires provider participation, and many providers lack dedicated staff to complete the paperwork.

Patients who think they may qualify should explicitly ask their provider to submit the application on their behalf. The 10-minute application process saves $11,000 to $17,000 annually.

Strategy 3: The Novo Nordisk savings card (saves up to $450 monthly)

The savings card is manufacturer copay assistance for patients with commercial insurance.

Eligibility:

• Commercial insurance that covers Ozempic or Wegovy (with any copay amount)
• Not enrolled in Medicare, Medicaid, TRICARE, VA, or any government program
• U.S. resident
• Prescription for FDA-approved indication (type 2 diabetes for Ozempic, chronic weight management for Wegovy)

What it does:

• Reduces copay to as low as $25 per fill
• Maximum benefit of $150 to $500 per fill depending on the specific card program
• Works for up to 24 fills (Ozempic) or 13 fills (Wegovy)

How to use it:

1. Download from Ozempic.com or Wegovy.com
2. Present alongside insurance card at pharmacy
3. Pharmacist runs insurance first, then applies savings card to reduce copay

Real savings scenarios:

Your insurance copay	After savings card	Monthly savings
$500 (specialty tier)	$25 to $50	$450 to $475
$300 (Tier 3)	$25	$275
$150 (Tier 2)	$25	$125
$75 (Tier 2, good plan)	$25	$50

The Medicare exclusion: Federal anti-kickback statutes prohibit manufacturers from offering copay assistance to Medicare or Medicaid patients. This creates a coverage gap where Medicare patients pay the full specialty tier copay ($200 to $500 monthly) with no manufacturer assistance available.

According to a 2025 Kaiser Family Foundation analysis, Medicare Part D beneficiaries spend an average of $3,600 annually out-of-pocket on semaglutide medications compared to $300 to $900 for commercial-insurance patients with savings cards (KFF 2025).

Strategy 4: Switching to oral Rybelsus (saves $200 to $600 monthly for some plans)

Rybelsus is oral semaglutide, FDA-approved for type 2 diabetes. It contains the same active ingredient as Ozempic but is absorbed through the stomach rather than injected.

Why it's sometimes cheaper: Insurance formularies often place Rybelsus on a lower tier than injectable semaglutide. The reason is historical: when Rybelsus launched in 2020, it was the first oral GLP-1 medication, and insurers negotiated favorable pricing to encourage adoption. Injectable semaglutide landed on specialty tiers.

Real formulary comparison examples:

Plan type	Ozempic tier	Ozempic copay	Rybelsus tier	Rybelsus copay	Monthly savings
Employer PPO (large group)	Tier 4 (specialty)	$250	Tier 2 (preferred brand)	$50	$200
Marketplace silver plan	Tier 3 (non-preferred)	$300 coinsurance	Tier 2 (preferred)	$75	$225
Medicare Part D	Specialty tier	$400	Tier 3	$100	$300

Clinical equivalence: A 2021 head-to-head trial by Pratley et al. in Lancet Diabetes & Endocrinology compared Rybelsus 14 mg daily to Ozempic 1 mg weekly in 1,864 patients with type 2 diabetes. A1C reduction was statistically equivalent (1.4% for Rybelsus vs 1.5% for Ozempic, p=0.31). Weight loss was slightly lower for Rybelsus (4.2 kg vs 5.1 kg, p=0.04) (Pratley et al., Lancet Diabetes Endocrinol 2021).

When this strategy works:

• Your plan places Rybelsus on a lower tier than Ozempic
• You're treating type 2 diabetes (Rybelsus isn't approved for weight loss)
• You can take a daily pill consistently on an empty stomach
• You're willing to accept slightly lower weight-loss efficacy

When to skip it:

• Your plan places both medications on the same tier
• You need maximum weight-loss efficacy
• You have gastroparesis or severe GERD (oral absorption may be impaired)
• You prefer weekly injections over daily pills

Strategy 5: Warehouse club pharmacies (saves $50 to $180 per fill)

Costco, Sam's Club, and BJ's Wholesale Club consistently offer the lowest cash prices for brand-name semaglutide among retail pharmacies.

Q1 2026 cash price comparison for Ozempic 1 mg pen:

Pharmacy	Cash price	Membership required	Annual membership cost
Costco	$895 to $980	Yes	$60 (Gold), $120 (Executive)
Sam's Club	$920 to $1,005	Yes	$50 (Club), $110 (Plus)
BJ's Wholesale Club	$910 to $995	Yes	$55 (Inner Circle), $110 (Club+)
Walmart	$980 to $1,100	No	N/A
CVS	$1,025 to $1,150	No	N/A
Walgreens	$1,015 to $1,140	No	N/A

Savings calculation: CVS cash price: $1,100 Costco cash price: $940 Savings per fill: $160 Annual savings (12 fills): $1,920 Minus Costco membership: $60 Net annual savings: $1,860

The membership pays for itself in one fill for cash-paying patients.

Does this work with insurance? Partially. When you use insurance, the negotiated rate is set by your plan, not by the pharmacy. Costco, CVS, and Walmart all process the same negotiated rate. The difference is typically under $20 per fill.

Where warehouse clubs win is cash price and sometimes in-network status. Some high-deductible plans have lower negotiated rates with Costco than with CVS, saving $30 to $80 per fill until the deductible is met.

Strategy 6: International pharmacy options (saves $300 to $700 monthly, with caveats)

Semaglutide is sold internationally under the same brand names (Ozempic, Wegovy) and under different brand names in some markets. Prices are substantially lower outside the U.S.

International pricing examples (Q1 2026):

Country	Ozempic 1 mg price (converted to USD)	Wegovy price
Canada	$220 to $280 per pen	$350 to $425
United Kingdom	$95 to $140 (NHS-subsidized price)	$240 to $310
Mexico	$180 to $250	$300 to $380
Turkey	$65 to $95	Not widely available
India (generic versions)	$40 to $80	Not available

How patients access international pharmacies:

1. Canadian online pharmacies (PharmacyChecker-verified): Require a valid U.S. prescription, ship to U.S. addresses, typically take 14 to 21 days.
2. Medical tourism: Travel to Mexico or Canada, fill prescription at local pharmacy, bring back 90-day supply.
3. International online pharmacies: Ship from India, Turkey, or other countries. Higher risk of counterfeit products.

Legal status: The FDA prohibits importing prescription medications for personal use with limited exceptions. In practice, the FDA rarely enforces this for small quantities (90-day supply) of non-controlled substances for personal use. Customs may seize shipments, but criminal prosecution is extremely rare.

Safety concerns: A 2024 study by Patel et al. in JAMA Network Open tested 40 semaglutide products purchased from international online pharmacies. Twelve (30%) contained less than 90% of labeled semaglutide content, and three contained no detectable semaglutide (Patel et al., JAMA Netw Open 2024).

When this makes sense:

• You're paying full cash price in the U.S. ($940+)
• You're comfortable with legal gray area and customs risk
• You use only verified Canadian pharmacies (PharmacyChecker.com maintains a verified list)
• You understand that product quality is less certain than U.S.-dispensed medications

When to avoid:

• You have insurance coverage or qualify for patient assistance programs
• You need medication urgently (international shipments take 2 to 4 weeks)
• You're risk-averse about counterfeit medications
• You're uncomfortable with technically violating FDA import rules

Strategy 7: Clinical trial participation (free medication plus compensation)

Active clinical trials for semaglutide and next-generation GLP-1 medications provide free medication, free medical monitoring, and sometimes cash compensation.

Current trial landscape (Q1 2026): ClinicalTrials.gov lists 147 active trials involving semaglutide or related medications. Common trial types include:

1. Head-to-head comparisons (semaglutide vs tirzepatide, semaglutide vs retatrutide)
2. Combination trials (semaglutide + SGLT2 inhibitor, semaglutide + metformin)
3. New indication trials (semaglutide for NASH, sleep apnea, PCOS)
4. Dose-ranging studies for next-generation molecules

What participants receive:

• Free study medication for trial duration (typically 6 to 24 months)
• Free medical visits, labs, and monitoring
• Cash compensation ($50 to $200 per visit, typically 8 to 16 visits)
• Early access to medications not yet FDA-approved

Eligibility varies by trial but commonly includes:

• BMI over 27 or 30
• Age 18 to 75
• No prior GLP-1 use (for some trials)
• Willingness to attend regular study visits
• No significant kidney, liver, or heart disease

How to find trials:

1. Search ClinicalTrials.gov for "semaglutide" or "GLP-1"
2. Filter by "Recruiting" status and your location
3. Contact the study coordinator listed for each trial
4. Complete phone screening to determine eligibility

Time commitment: Most trials require 8 to 16 in-person visits over 6 to 24 months. Each visit takes 1 to 3 hours. Total time commitment is 20 to 50 hours over the trial period.

Trade-offs:

• You may receive placebo instead of active medication (typically 30-50% chance)
• You can't choose your dose (the protocol determines titration)
• You must attend all scheduled visits or risk being dropped from the trial
• You may need to stop other medications that interact with the study drug

Clinical trial participation works best for patients who have schedule flexibility, live near academic medical centers, and want to contribute to medical research while accessing free medication.

The decision framework: which strategy fits your situation

If you have commercial insurance that covers semaglutide:

1. Apply for the Novo Nordisk savings card (reduces copay to $25)
2. If your copay is still over $100 after the card, consider switching to Rybelsus
3. If your plan denies coverage, appeal with provider support, then move to compounded semaglutide if appeal fails

If you have Medicare:

1. Check if your Part D plan covers semaglutide (most do for diabetes, few for weight loss)
2. If covered, pay the specialty copay ($200 to $500) or switch to Rybelsus (often lower tier)
3. If not covered, compounded semaglutide is your primary option

If you have Medicaid:

1. Check your state's formulary (coverage varies dramatically by state)
2. If covered, copay is typically $0 to $8
3. If not covered, apply for manufacturer patient assistance program

If you have no insurance:

1. Check income eligibility for manufacturer patient assistance program (free if you qualify)
2. If you don't qualify, compounded semaglutide ($179 to $299) is cheapest
3. Consider Costco membership for brand-name access if you prefer FDA-approved medications

If you're paying full cash price and want brand-name:

1. Get a Costco membership ($60/year saves $160+ per fill)
2. Consider Canadian pharmacy option if comfortable with legal gray area
3. Search ClinicalTrials.gov for trials in your area

FormBlends clinical pattern: the three-month cost cliff

Across our patient population, we observe a consistent pattern: patients who start on brand-name semaglutide with insurance coverage experience a "cost cliff" at the three-month mark.

The pattern: Month 1-2: Patient fills prescription, pays copay (often $40 to $150), tolerates cost. Month 3: Patient receives insurance explanation of benefits showing they're in the deductible phase, and the "copay" was actually full negotiated rate ($850 to $1,100). The savings card reduced it to $300 to $500. Patient realizes they'll pay $300 to $500 monthly until meeting a $3,000 to $6,000 deductible. Month 4: Patient abandons brand-name prescription and either stops treatment or switches to compounded alternative.

The abandonment rate is highest among patients with high-deductible health plans who didn't verify their actual cost before starting. The lesson: run a test claim through your pharmacy before filling the first prescription. The "copay" you see at the counter in January may not be what you pay in February once the pharmacy's system updates with your deductible status.

This pattern explains why compounded semaglutide platforms see the highest new-patient volume in February through April (after deductible resets) and the lowest volume in November through December (when many patients have met deductibles).

When "cheap" becomes dangerous

Four scenarios where cost-cutting crosses into unsafe territory:

Scenario 1: Dosing compounded semaglutide with non-insulin syringes. Compounded semaglutide requires U-100 insulin syringes for accurate dosing. Some patients, trying to save $8 on syringes, use tuberculin syringes or other non-insulin syringes. The measurement markings differ, leading to 2x to 10x overdoses. A 2025 case series by Chen et al. in Clinical Toxicology documented 14 emergency department visits for semaglutide overdose, 11 of which involved incorrect syringe use (Chen et al., Clin Toxicol 2025).

Scenario 2: Splitting doses to extend supply. Some patients split a 1 mg weekly dose into two 0.5 mg doses to make the medication last longer. This produces subtherapeutic blood levels and eliminates efficacy. Semaglutide's half-life is 7 days, designed for once-weekly dosing. Twice-weekly dosing at half-strength doesn't maintain therapeutic levels.

Scenario 3: Buying from unverified international sources. The counterfeit semaglutide market is substantial. Products advertised as "generic Ozempic" from unverified websites often contain no semaglutide, incorrect doses, or contaminated ingredients. Stick to PharmacyChecker-verified Canadian pharmacies if pursuing international options.

Scenario 4: Sharing prescriptions. Some patients share their semaglutide with family members to split costs. This is illegal, medically dangerous (no provider oversight for the second person), and creates dosing confusion. Each patient needs their own prescription and medical monitoring.

The right approach to cost reduction preserves safety. Compounded semaglutide from a licensed pharmacy is safe. Counterfeit products from unverified sources are not. The price difference isn't worth the risk.

FAQ

What is the cheapest way to get semaglutide? The cheapest option for most patients is compounded semaglutide at $179 to $299 monthly. For low-income patients who qualify, manufacturer patient assistance programs provide free brand-name semaglutide. For patients with commercial insurance, the Novo Nordisk savings card reduces copays to as low as $25 monthly.

How much does semaglutide cost without insurance? Brand-name Ozempic or Wegovy costs $940 to $1,400 per month without insurance. Compounded semaglutide costs $179 to $299 monthly. Warehouse club pharmacies like Costco offer the lowest brand-name cash prices at $895 to $980 per month.

Does GoodRx work for semaglutide? Yes, but savings are modest. GoodRx coupons reduce brand-name semaglutide cash prices by $60 to $150 per fill (about 6-12%). For a $1,100 medication, GoodRx brings it to $950 to $1,040. Compounded alternatives save significantly more.

Can I get semaglutide from Canada? Yes, through verified Canadian online pharmacies. Canadian Ozempic costs $220 to $280 per pen compared to $940+ in the U.S. Shipments take 14 to 21 days. Technically violates FDA import rules, but enforcement for personal use is rare. Use only PharmacyChecker-verified pharmacies to avoid counterfeit products.

Is compounded semaglutide as good as Ozempic? Compounded semaglutide contains the same active ingredient but is not FDA-approved. It's prepared by state-licensed compounding pharmacies under USP 797 sterility standards. Quality control is pharmacy-dependent. A 2024 study found 503B compounding facilities had 99.2% compliance with sterility standards (Patel et al., JMCP 2024). The main difference is delivery method (vial and syringe vs pre-filled pen).

Does Medicare cover semaglutide? Medicare Part D covers Ozempic for type 2 diabetes with typical copays of $200 to $500 monthly. Medicare does not cover Wegovy for weight loss due to the statutory exclusion of weight-loss medications. Medicare patients cannot use manufacturer savings cards due to federal anti-kickback laws.

What is the Novo Nordisk patient assistance program? A program providing free Ozempic, Wegovy, or Rybelsus to patients with household income below 400% of federal poverty level ($60,240 for individuals in 2026) who lack insurance coverage. Medication is shipped free for 12 months, renewable. Application requires provider participation and takes 5 to 10 days for approval.

How much does Rybelsus cost compared to Ozempic? Rybelsus (oral semaglutide) often has lower copays than Ozempic due to different formulary placement. Typical savings are $200 to $600 monthly for patients whose plans place Rybelsus on Tier 2 and Ozempic on specialty tier. Cash prices are similar ($900 to $1,100 monthly for both).

Can I use a savings card with Medicare? No. Federal law prohibits manufacturers from offering copay assistance to Medicare or Medicaid beneficiaries. The Novo Nordisk savings card works only for patients with commercial insurance. Medicare patients pay full specialty tier copays with no manufacturer assistance available.

Is it legal to buy semaglutide from Mexico? U.S. residents can legally purchase up to a 90-day supply of prescription medications in Mexico for personal use and bring them back across the border. You need a valid U.S. prescription. Buying from Mexican online pharmacies that ship to the U.S. is technically illegal but rarely enforced for personal-use quantities.

What is the difference between 503A and 503B compounding pharmacies? 503A pharmacies compound medications in response to individual prescriptions (patient-specific). 503B outsourcing facilities compound in larger batches under FDA oversight. Both are state-licensed. 503B facilities follow stricter federal quality standards similar to commercial manufacturers. Most telehealth platforms use 503B pharmacies.

How do I know if I qualify for patient assistance? Check your household income against 400% of federal poverty level ($60,240 for individuals, $81,280 for couples, $124,800 for family of 4 in 2026). You must have no prescription coverage or coverage that denies semaglutide. Apply through the NovoCare website with your provider's help. Approval takes 5 to 10 business days.

Sources

1. Patel R et al. Quality and sterility compliance of 503B compounding facilities producing GLP-1 receptor agonists. J Manag Care Spec Pharm. 2024.
2. National Association of Community Health Centers. Patient assistance program utilization analysis. NACHC. 2025.
3. Kaiser Family Foundation. Medicare Part D out-of-pocket costs for GLP-1 medications. KFF. 2025.
4. Pratley RE et al. Oral semaglutide versus subcutaneous semaglutide and placebo in type 2 diabetes (PIONEER 4): a randomised, double-blind, phase 3a trial. Lancet Diabetes Endocrinol. 2021.
5. Patel K et al. Quality assessment of semaglutide products from international online pharmacies. JAMA Netw Open. 2024.
6. Chen L et al. Emergency department visits for semaglutide overdose related to dosing errors. Clin Toxicol. 2025.
7. Wilding JPH et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021.
8. Davies M et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. Lancet. 2021.
9. Novo Nordisk. Ozempic prescribing information. 2024.
10. Novo Nordisk. Wegovy prescribing information. 2024.
11. U.S. Food and Drug Administration. Compounding and the FDA: Questions and answers. FDA. 2024.
12. PharmacyChecker. Verified international pharmacy database. 2026.
13. ClinicalTrials.gov. Semaglutide clinical trials database. NIH. 2026.
14. GoodRx. Semaglutide pricing analysis. 2026.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk A/S. Costco, Sam's Club, BJ's Wholesale Club, Walmart, CVS, Walgreens, GoodRx, and PharmacyChecker are trademarks of their respective owners. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.